Vaccines

04 Aug 2010 TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine
03 Aug 2010 Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival
03 Aug 2010 Advaxis Gets Formal Go-Ahead from India's DCGI to Conduct Phase II Cervical Cancer Trial
02 Aug 2010 FDA Approves Vaccines for the 2010-2011 Influenza Season
28 Jul 2010 Oxford BioMedica Announces FDA Approval for TroVax Phase II Study in Prostate Cancer
28 Jul 2010 Etubics Enters Phase I Cancer Clinical Trials Focused on Colorectal Cancer
28 Jul 2010 Advaxis Phase I Survival Update
27 Jul 2010 Sinopharm and Merck Sign Statement of Mutual Intent
27 Jul 2010 Dynavax Completes Enrollment and First Immunizations in Universal Flu Vaccine Study
27 Jul 2010 Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial
26 Jul 2010 FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID, Targeting Mantle Cell Lymphoma
26 Jul 2010 Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and Demonstrate Significant Therapeutic Benefit in Animal Models
22 Jul 2010 MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma
19 Jul 2010 Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naïve Individuals
19 Jul 2010 Phase II Data from FIT Biotech's HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
19 Jul 2010 Argos Therapeutics' Arcelis HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study
16 Jul 2010 A*STAR & CYTOS BIOTECHNOLOGY ESTABLISH INFLUENZA VACCINE COLLABORATION
15 Jul 2010 PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
15 Jul 2010 Aduro BioTech Announces Key Milestones in Advancing Its Leading Listeria-Based Immunotherapy Program
14 Jul 2010 Nabi Biopharmaceuticals Completes Enrollment of First NicVAX Phase III Clinical Trial
13 Jul 2010 Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
12 Jul 2010 Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA
08 Jul 2010 Crucell Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines
08 Jul 2010 PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
07 Jul 2010 Dynavax Initiates First Human Trial in Universal Flu Vaccine Program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top